Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Revenue

In the year 2023, Pacira BioSciences had annual revenue of $674.98M with 1.22% growth. Revenue in the quarter ending December 31, 2023 was $181.24M with 5.40% year-over-year growth.

• Revenue (ttm): $674.98M
• Revenue Growth: +1.22%
• P/S Ratio: 1.86
• Revenue / Employee: $948,003
• Employees: 712
• Market Cap: 1.25B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	674.98M	8.16M	1.22%
Dec 31, 2022	666.82M	125.29M	23.14%
Dec 31, 2021	541.53M	111.89M	26.04%
Dec 31, 2020	429.65M	8.62M	2.05%
Dec 31, 2019	421.03M	83.75M	24.83%
Dec 31, 2018	337.28M	50.65M	17.67%
Dec 31, 2017	286.63M	10.26M	3.71%
Dec 31, 2016	276.37M	27.37M	10.99%
Dec 31, 2015	249.00M	51.33M	25.97%
Dec 31, 2014	197.67M	112.12M	131.05%
Dec 31, 2013	85.55M	46.47M	118.89%
Dec 31, 2012	39.08M	23.40M	149.12%
Dec 31, 2011	15.69M	1.13M	7.74%
Dec 31, 2010	14.56M	-444.00K	-2.96%
Dec 31, 2009	15.01M	1.08M	7.76%
Dec 31, 2008	13.93M	5.58M	66.95%
Dec 31, 2007	8.34M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.